Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England

Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013–June 2014

(2015) Penina Haber et al.   VACCINE

Vaxtracker: Active on-line surveillance for adverse events following inactivated influenza vaccine in children

(2014) Patrick Cashman et al.   VACCINE

Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005–June 2013

(2014) Penina Haber et al.   VACCINE

Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: The importance of routine active safety surveillance

(2012) Helen Petousis-Harris et al.   VACCINE

The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults

(2012) Christopher S. Ambrose et al.   VACCINE

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults

(2011) Stan L. Block et al.   VACCINE

Efficacy and Safety of 1 and 2 Doses of Live Attenuated Influenza Vaccine in Vaccine-Naive Children

(2009) Humberto Bracco Neto et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL